Molecular Mechanisms of Transcription Factor 4 in Pitt-Hopkins Syndrome
- 79 Downloads
Purpose of Review
Pitt-Hopkins syndrome (PTHS) is a rare neurodevelopmental disorder that results from mutations of the clinically pleiotropic transcription factor 4 (TCF4) gene. Mutations in the genomic locus of TCF4 on chromosome 18 have been linked to multiple disorders including 18q syndrome, schizophrenia, Fuch’s corneal dystrophy, and sclerosing cholangitis. For PTHS, TCF4 mutation or deletion leads to the production of a dominant negative TCF4 protein and/or haploinsufficiency that result in abnormal brain development. The biology of TCF4 has been studied for several years in regard to its role in immune cell differentiation, although its role in neurodevelopment and the mechanisms resulting in the severe symptoms of PTHS are not well studied.
Here, we summarize the current understanding of PTHS and recent findings that have begun to describe the biological implications of TCF4 deficiency during brain development and into adulthood. In particular, we focus on recent work that has looked at the role of TCF4 biology within the context of PTHS and highlight the potential for identification of therapeutic targets for PTHS.
PTHS research continues to uncover mutations in TCF4 that underlie the genetic cause of this rare disease, and emerging evidence for molecular mechanisms that TCF4 regulates in brain development and neuronal function is contributing to a more complete picture of how pathology arises from this genetic basis, with important implications for the potential of future clinical care.
KeywordsPitt-Hopkins syndrome Transcription factor 4 TCF4 ITF2 SEF2 E2-2 Autism spectrum
This work was supported by NIH grant (R56MH104593) and Pitt-Hopkins Research Foundation Award to B.J.M.
Compliance with Ethics Standards
Conflict of Interest
Matthew D. Rannals declares that he has no conflict of interest.
Brady J. Maher reports grants from the NIH/NIMH during the conduct of study. He reports employment at the Lieber Institute for Brain Development and grants from NIMH outside of the submitted work.
Human and Animal Rights and Informed Consent
This article does not contain any studies with human or animal subjects performed by any of the authors.
Papers of particular interest, published recently, have been highlighted as : • Of importance
- 1.Amiel J, Rio M, de Pontual L, et al. Mutations in TCF4, encoding a class I basic helix-loop-helix transcription factor, are responsible for Pitt-Hopkins syndrome, a severe epileptic encephalopathy associated with autonomic dysfunction. Am J Hum Genet. 2007;80:988–93.CrossRefPubMedPubMedCentralGoogle Scholar
- 4.• Sepp M, Pruunsild P, Timmusk T. Pitt-Hopkins syndrome-associated mutations in TCF4 lead to variable impairment of the transcription factor function ranging from hypomorphic to dominant-negative effects. Hum Mol Genet. 2012;21:2873–88. Description of PTHS-related mutations in relation to resulting TCF4 function. Evidence of a range of mutation impact from subtle deficiencies to dominant-negative effects CrossRefPubMedGoogle Scholar
- 24.Henthorn P, Kiledjian M, Kadesch T. Two distinct transcription factors that bind the immunoglobulin enhancer uE5/kE2 motif. Science. 1990;247:467–70.Google Scholar
- 33.• Rannals MD, Hamersky GR, Page SC, et al. Psychiatric risk gene transcription factor 4 regulates intrinsic excitability of prefrontal neurons via repression of SCN10a and KCNQ1. Neuron. 2016;90:43–55. First report of TCF4 directly regulating neuronal excitability. Haploinsufficiency of TCF4 results in the loss of repression of the ion channel gene SCN10a which becomes ectopically expressed and represents a potential therapeutic target CrossRefPubMedGoogle Scholar
- 40.Larsson G, Schleucher J, Onions, et al. A novel target recognition revealed by calmodulin in complex with basic helix–loop–helix transcription factor SEF2–1/E2–2. Protein Sci. 2001;10:169–86.Google Scholar
- 60.• Kennedy AJ, Rahn EJ, Paulukaitis BS, et al. Tcf4 regulates synaptic plasticity, DNA methylation, and memory function. CellReports. doi: 10.1016/j.celrep.2016.08.004. Evidence that HDAC inhibitors can alleviate learning and memory deficits in a PTHS mouse model. Also provides a thorough description of behavioral phenotypes that mirror other ASD mouse models
- 61.Crawley JN. Designing mouse behavioral tasks relevant to autistic-like behaviors. Ment Retard Dev Disabil Res Rev. 2004;10:248–58.Google Scholar
- 66.Vijayaragavan K, O’Leary ME (2001) Gating properties of Nav1. 7 and Nav1. 8 peripheral nerve sodium channels. Journal of NeuroscienceGoogle Scholar
- 68.• D’Rozario M, Zhang T, Waddell EA, et al. Type I bHLH proteins daughterless and Tcf4 restrict neurite branching and synapse formation by repressing Neurexin in postmitotic neurons. Cell Rep. 2016;15:386–97. Description of TCF4 playing a role in postmitotic neuronal function. Functional expression of TCF4 in postmitotic neurons restricts neurite branching and regulates synapse number CrossRefPubMedPubMedCentralGoogle Scholar
- 82.Hamdan FF, Daoud H, Patry L, et al. Parent-child exome sequencing identifies a de novo truncating mutation in TCF4 in non-syndromic intellectual disability. Clin Genet. 2013;83:198–200.Google Scholar